Basics Tenaya Therapeutics, Inc. IPO Date: June 30, 2021 Sector: Healthcare Industry: Biotech Market Cap: $234.77M Activated in VL: True Average Daily Range Avg Daily Range: $0.28 | 4.67% Avg Daily Range (30 D): $0.06 | 4.82% Avg Daily Range (90 D): $0.06 | 4.85% Institutional Daily Volume Avg Daily Volume: 1.05M Avg Daily Volume (30 D): 2.88M Avg Daily Volume (90 D): 3.46M Trade Size Avg Trade Size (Sh.): 253 Avg Trade Size (Sh.) (30 D): 421 Avg Trade Size (Sh.) (90 D): 439 Institutional Trades Total Inst.Trades: 106 Avg Inst. Trade: $1.63M Avg Inst. Trade (30 D): $.53M Avg Inst. Trade (90 D): $.53M Avg Inst. Trade Volume: .39M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.09M Avg Closing Trade (30 D): $.53M Avg Closing Trade (90 D): $.53M Avg Closing Volume: 588.63K     News Nov 8, 2025 @ 4:25 PM Tenaya Therapeutics Presents Promising Interim Cli... Source: Tenaya Therapeutics Aug 31, 2025 @ 2:15 PM Tenaya Therapeutics Presents Interim Data from MyC... Source: Tenaya Therapeutics Mar 4, 2025 @ 3:55 PM 2025 Market Prospects of Adeno-Associated Virus Ve... Source: Researchandmarkets.Com Jun 27, 2024 @ 9:00 PM Tenaya Therapeutics Announces Research Leadership ... Source: Tenaya Therapeutics, Inc. Jun 18, 2024 @ 8:30 PM Tenaya Therapeutics to Participate at the TD Cowen... Source: Tenaya Therapeutics, Inc. Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.75 $-.12 $-.14 Diluted EPS $-.75 $-.12 $-.14 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -94.26M $ -20.28M $ -23.28M Operating Income / Loss $ -97.21M $ -20.94M $ -24.08M Cost of Revenue $ $ $ Net Cash Flow $ 48.08M $ -6.36M $ 8.9M PE Ratio